RGD Reference Report - Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.

Authors: Lotan, TL  Lyon, M  Huo, D  Taxy, JB  Brendler, C  Foster, BA  Stadler, W  Rinker-Schaeffer, CW 
Citation: Lotan TL, etal., J Pathol. 2007 Aug;212(4):386-94.
RGD ID: 2293334
Pubmed: PMID:17577251   (View Abstract at PubMed)
DOI: DOI:10.1002/path.2194   (Journal Full-text)

Identification of the signalling cascades that are differentially activated during prostatic tumourigenesis is a crucial step in the search for future molecular targets in this disease. The stress-activated protein kinase (SAPK) signalling cascade culminates in the phosphorylation of the JNK and p38 mitogen-activated protein kinases (MAPKs). Recently, the upstream activators of these proteins, the MAPK kinases (MKKs), have been implicated as inhibitors of tumour progression in a variety of clinical and experimental tumour models. This study evaluates MKK4, MKK6 and MKK7 expression during prostate cancer progression in humans and in the transgenic adenocarcinoma of a mouse prostate (TRAMP) model of prostate tumourigenesis. Benign prostate, prostatic intraepithelial neoplasia (PIN) lesions and tumour tissues were collected from 37 TRAMP mice. Additionally, six tissue microarrays were constructed with tumours from a matched group of 102 men who underwent radical prostatectomy. Tissues from 20 patients with extensive high-grade prostatic intraepithelial neoplasia (HGPIN) were also analysed. For all samples, immunohistochemical staining for MKK4, MKK6 and MKK7 was scored in normal and neoplastic glands. Staining intensities of MKK4, MKK6 and MKK7 were significantly increased in HGPIN and prostate cancer compared to surrounding normal glands in both the TRAMP and human samples (p < 0.0001 for all markers). Increased levels of MKK4 or MKK7 correlated with higher pathological stage at prostatectomy (p = 0.01 and p = 0.04). Using multivariate analysis, there was no association between protein levels and time to biochemical recurrence in the human samples. The up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression in both TRAMP and human tissues highlights an important role for the SAPK signalling cascade in prostatic neoplasia. The finding that higher MKK4 and MKK7 expression is associated with higher-stage prostatic tumours underscores the dynamic regulation of these proteins during prostatic tumourigenesis.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
prostate carcinoma in situ disease_progressionIEP 2293334; 2293334; 2293334protein:increased expressionRGD 
prostate carcinoma in situ disease_progressionISOMAP2K4 (Homo sapiens)2293334; 2293334 RGD 
prostate carcinoma in situ disease_progressionISOMAP2K6 (Homo sapiens)2293334; 2293334 RGD 
prostate carcinoma in situ disease_progressionISOMAP2K7 (Homo sapiens)2293334; 2293334 RGD 
Prostatic Neoplasms  IEP 2293334; 2293334; 2293334; 2293334; 2293334; 2293334protein:increased expression:tumor:increased in high-grade prostatic intraepithelial neoplasias and tumor tissues (p<0.0001)RGD 
Prostatic Neoplasms  ISOMAP2K4 (Homo sapiens)2293334 RGD 
Prostatic Neoplasms  ISOMAP2K6 (Homo sapiens)2293334 RGD 
Prostatic Neoplasms  ISOMAP2K7 (Homo sapiens)2293334 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Map2k4  (mitogen activated protein kinase kinase 4)
Map2k6  (mitogen-activated protein kinase kinase 6)
Map2k7  (mitogen activated protein kinase kinase 7)

Genes (Mus musculus)
Map2k4  (mitogen-activated protein kinase kinase 4)
Map2k6  (mitogen-activated protein kinase kinase 6)
Map2k7  (mitogen-activated protein kinase kinase 7)

Genes (Homo sapiens)
MAP2K4  (mitogen-activated protein kinase kinase 4)
MAP2K6  (mitogen-activated protein kinase kinase 6)
MAP2K7  (mitogen-activated protein kinase kinase 7)


Additional Information